2021
DOI: 10.1186/s13020-021-00427-0
|View full text |Cite
|
Sign up to set email alerts
|

The important herbal pair for the treatment of COVID-19 and its possible mechanisms

Abstract: Background Coronavirus Disease 2019 (COVID-19) is an unprecedented disaster for people around the world. Many studies have shown that traditional Chinese medicine (TCM) are effective in treating COVID-19. However, it is difficult to find the most effective combination herbal pair among numerous herbs, as well as identifying its potential mechanisms. Herbal pair is the main form of a combination of TCM herbs, which is widely used for the treatment of diseases. It can also help us to better under… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
18
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 28 publications
(18 citation statements)
references
References 39 publications
0
18
0
Order By: Relevance
“…Additionally, some of the purple module hub-high traffic genes, such as MAPK1 ( 189 , 374 ), CUL2 ( 210 ), CMTM6 ( 162 ), TXNRD1 ( 375 ), RAB1A ( 376 ), DICER1 ( 377 ), RAB5A ( 209 ), HSP90B1 ( 343 ), MAGT1 ( 378 ), ADAM10 ( 379 , 380 ), SNX2 ( 89 ), OLA1 ( 381 ), SPTLC1 ( 382 ), SH3GLB1 ( 383 ), TIMM10B ( 384 ), and CREB1 ( 385 ) hub-high traffic TF, which are central for information exchange in this module, are potential targets for development of COVID-19 therapeutic strategies. Among these, the mitogen-activated protein kinase 1 ( MAPK1 ) hub-high traffic gene is a potential core target for many anti-COVID-19 therapeutic strategies ( 189 , 374 , 386 390 ). Perhaps targeting the MAPK1 hub-high traffic gene with guanfacine or desipramine may be effective for treating COVID-19 associated comorbidities, such as diabetes, CVDs, and chronic kidney diseases (CKDs) ( 139 ).…”
Section: Discussionmentioning
confidence: 99%
“…Additionally, some of the purple module hub-high traffic genes, such as MAPK1 ( 189 , 374 ), CUL2 ( 210 ), CMTM6 ( 162 ), TXNRD1 ( 375 ), RAB1A ( 376 ), DICER1 ( 377 ), RAB5A ( 209 ), HSP90B1 ( 343 ), MAGT1 ( 378 ), ADAM10 ( 379 , 380 ), SNX2 ( 89 ), OLA1 ( 381 ), SPTLC1 ( 382 ), SH3GLB1 ( 383 ), TIMM10B ( 384 ), and CREB1 ( 385 ) hub-high traffic TF, which are central for information exchange in this module, are potential targets for development of COVID-19 therapeutic strategies. Among these, the mitogen-activated protein kinase 1 ( MAPK1 ) hub-high traffic gene is a potential core target for many anti-COVID-19 therapeutic strategies ( 189 , 374 , 386 390 ). Perhaps targeting the MAPK1 hub-high traffic gene with guanfacine or desipramine may be effective for treating COVID-19 associated comorbidities, such as diabetes, CVDs, and chronic kidney diseases (CKDs) ( 139 ).…”
Section: Discussionmentioning
confidence: 99%
“…We found that both QPD and XBD suppressed NF-κB signaling, to a striking degree. Moreover, network pharmacology studies ( Li et al, 2021 ; Niu et al, 2021 ; Xia et al, 2021 ) have revealed that numerous active compounds in TCM have significant molecular binding affinities with IL-6 or could block IL-6 mediated JAK-STAT signaling pathway, raising another possibility for the anti-inflammatory activity of TCM.…”
Section: Discussionmentioning
confidence: 99%
“…Anti-viral: COV2 by binding affinity to 3CL pro [421]; to 3pro and ACE2 [422] Cinnamon (Cinnamomum) Camphor: 60% in root bark [426] Anti-inflammation [278,296] Cinnamaldehyde: 65%-80% in bark [426] Anti-viral: [ Anti-inflammation [11,238,241,261,262,265,267,291,400] p-Cymene: 42.1% in leaf and 30.0% in fruit [438] Anti-inflammation [322,328] Limonene: 5.5% in leaf and none in fruit [438], 1.33% in E. lehmani leaves and 3.32% in E. sideroxylon leaves [300], from 0% to 28% depending on the species and location [439] Anti-inflammation [275,278,297] α-Pheliandrene: from 0% to 20.1% depending on the species and location [439] Anti-inflammation [278] α-Pinene: 12.7% in leaf and 9.0% in fruit [438], from 1.27% to 26.35% in 7 Eucalyptus species' leaves with highest in E. lehmani [300], from 0% to 52.7% depending on the species and location [439] Anti-inflammation [278,337] Spathulenol: 3.2% in leaf and none in fruit [438], 1.15% in E. astrengens leaves [300], from 0% to 41.5% depending on the species and location [439] Anti-inflammation [387] γ -Terpinene: none in leaf and 5.1% in fruit [438], from 0% to 29.2% depending on the species and location [439] Anti-inflammation [278,…”
Section: Luteolinmentioning
confidence: 99%